Karl Utermohlen

Karl Utermohlen

Recent Articles

Adidas AG (ADR) (ADDYY) Posts Wide Q4 Loss on Tax Charge

Adidas (ADDYY) announced its latest quarterly earnings results Wednesday, which saw the company's loss quadruple year-over-year, while sales were higher.

Noodles & Co (NDLS) Q4 Earnings Top Analysts’ Expectations

Noodles & Co (NDLS) reported better-than-expected quarterly results Wednesday, with its fourth quarter yielding an adjusted profit of a penny per share.

Inovio Pharmaceuticals Inc (INO) Q4 Revenue Grew 3.5% Year-Over-Year

Inovio Pharmaceuticals (INO) posted its latest quarterly earnings results, which saw revenue grow more than 3% for the quarter and nearly 20% for the year.

Williams-Sonoma, Inc. (WSM) Q4 Revenue Rises 4% Y2Y

Williams-Sonoma (WSM) reported on its fourth quarter after the bell Wednesday, posting earnings and revenue that topped analysts' expectations.

3D Systems Corporation (DDD) Q4 Earnings Top Expectations

3D Systems (DDD) shares were soaring Wednesday as the company reported its latest quarterly earnings results. The company turned a profit of 5 cents per share.

3 Stocks to Watch on Wednesday: Caleres Inc (CAL), Everi Holdings Inc (EVRI) and Natera Inc (NTRA)

Caleres (CAL), Everi Holdings (EVRI) and Natera (NTRA) all reported on their quarterly earnings results after the bell. Here's what you should know.

Consumer Group Claims Claire’s Makeup Contained Abestos

Claire's Makeup products reportedly have asbestos, according to consumer group U.S. Public Interest Research Group (PIRG), which discovered this in a test.

Fitbit Ace: Fitbit Launches Fitness Tracker for Kids

Fitbit Ace is the name of the latest fitness tracker from Fitbit (FIT) and it's designed for children. Here's what you should know about it.

8 St. Patrick’s Day Traditions to Celebrate Ireland’s Patron Saint

We have compiled eight of the best St. Patrick's Day traditions to celebrate Ireland's patron saint, who wasn't even Irish. Check them out ahead of the big day.

Proteostasis Therapeutics Inc (PTI) Soars on Cystic Fibrosis Approval

Proteostasis Therapeutics (PTI) shares were soaring as the company's cystic fibrosis drug received approval from the Food and Drug Administration (FDA).